Status:
COMPLETED
Patient Preference for Mouthpiece Ventilation
Lead Sponsor:
Revalidatieziekenhuis InkendaaI
Conditions:
Neuromuscular Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
BACKGROUND: Patients with severe neuromuscular disorders (NMDs) are likely to develop progressive respiratory insufficiency, leading to noninvasive ventilation during the night and, later, during nig...
Detailed Description
Materials and Methods Aims The primary aim of the study was to compare blood gas measurements, dyspnea score and general perception between the two sets for MPV. The second aim of the study was to d...
Eligibility Criteria
Inclusion
- All individuals affected by NMDs attending our Centre for Home Mechanical Ventilation between January 2015 and December 2018 who required daytime MPV as an extension of nocturnal NIV
Exclusion
- Patients with no need for daytime ventilation
- patients with ineffective NIV during sleep as assessed by the measurement of TcCO2\>49mmHg (S)
- patients with uncontrollable oral leaks with MPV or episode of acute respiratory infection during the trials
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03867721
Start Date
January 1 2015
End Date
December 30 2018
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michel Toussaint
Vlezenbeek, Belgium, 1602